Cyprus pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$528.7 million | 95.1% |
| 3003 Medicaments | US$17.8 million | 3.2% |
| 3006 Pharmaceutical goods | US$6.2 million | 1.1% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$2.4 million | 0.4% |
| 3002 Human blood | US$675,000 | 0.1% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$385,000 | 0.1% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$431.9 million | 77.6% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$28.2 million | 5.1% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$27.1 million | 4.9% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$20.1 million | 3.6% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$13.7 million | 2.5% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$13.6 million | 2.4% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$5.7 million | 1.0% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$4.4 million | 0.8% |
| 300339 Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | US$3.6 million | 0.7% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$2.0 million | 0.4% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$495.2 million | 84.4% |
| 3002 Human blood | US$59.3 million | 10.1% |
| 3006 Pharmaceutical goods | US$13.0 million | 2.2% |
| 3003 Medicaments | US$10.6 million | 1.8% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$7.8 million | 1.3% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$1.2 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$438.1 million | 74.6% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$40.7 million | 6.9% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$15.5 million | 2.6% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$12.4 million | 2.1% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$11.1 million | 1.9% |
| 300220 Vaccines: for human medicine | US$10.4 million | 1.8% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$9.4 million | 1.6% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$6.5 million | 1.1% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$5.2 million | 0.9% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$4.8 million | 0.8% |
Shares are of Cyprus's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Cyprus's trade.
More Cyprus products
- 27 Mineral fuels, mineral oils and products of their distillation
- 89 Ships, boats and floating structures
- 87 Vehicles
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 85 Electrical machinery and equipment and parts thereof
- 04 Dairy produce
- 39 Plastics and articles thereof
- 72 Iron and steel
- 22 Beverages, spirits and vinegar
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 94 Furniture
- 33 Essential oils and resinoids
Cyprus pharmaceutical products: questions and answers
How much pharmaceutical products does Cyprus export?
In 2024, Cyprus exported US$556.2 million of pharmaceutical products (HS chapter 30), 10.2% of its total exports. That ranks it 48 of 213 exporting countries in the data.
What are Cyprus' biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$528.7 million), Medicaments (3003, US$17.8 million), Pharmaceutical goods (3006, US$6.2 million).
How much pharmaceutical products does Cyprus import?
In 2024, Cyprus imported US$587.1 million of pharmaceutical products (HS chapter 30), 4.1% of its total imports. That ranks it 83 of 226 importing countries in the data.
What are Cyprus' biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$495.2 million), Human blood (3002, US$59.3 million), Pharmaceutical goods (3006, US$13.0 million).
